achievelifesciences.com (ACHV) - Cash on Hand per Share

Corporate emblem and logo of Achieve Life Sciences Inc (ACHV)

Achieve Life Sciences (ACHV) is accelerating the rollout of its smoking cessation therapy through partnerships with research centers. The cash per share calculation demonstrates current liquidity, with the value of 1.81 capturing the metric level. High regulatory expenses for the approval of citizincletide are currently depleting the firm's capital. Consequently, Achieve Life Sciences is establishing a global support system for individuals overcoming tobacco addiction.

Achieve Life Sciences Inc. (ACHV) - Cash Funds per Share from 07/04/2022 to 11/10/2026

Comprehensive metric breakdowns and analytics for Achieve Life Sciences (ACHV)

- cash position and cash flow details:
Summary company analysis:ACHV (Achieve Life Sciences)
Manufactured product of Achieve Life Sciences Inc

For the biotechnology sector, Achieve Life Sciences (ACHV) must maintain critical liquidity until it secures FDA approval and monetizes its licenses. This metric is calculated by dividing total cash reserves by the number of shares outstanding, allowing investors to assess the company's actual financial runway and the risk of equity dilution, which is clearly reflected in the cash per share figure.